ADHD and Dementia Risk: Why Long-Term ADHD Treatment Should Be More Than Medication
TL;DR
A new 2026 study in JAMA Psychiatry found that adults with ADHD had a substantially higher rate of later-life mild cognitive impairment or dementia than adults without ADHD. The study does not prove that ADHD causes dementia, and it does not show that ADHD medication causes cognitive decline.
In fact, researchers still do not know whether ADHD treatment increases, decreases, or has no effect on dementia risk.
What it does suggest is that we should think about ADHD as more than a productivity problem.
For long-term brain health, ADHD treatment should address sleep, exercise, nutrition, cardiovascular and metabolic health, psychological skills, stress, substance use, relationships, and the patient's broader environment.
Medication can be tremendously helpful, but medication alone cannot address all of those factors.
That is one reason I favor an integrative approach to adult ADHD treatment.
What did the new JAMA Psychiatry study find?
The study found an association between ADHD and an increased risk of later-life mild cognitive impairment or dementia.
Researchers analyzed 187,341 adults age 50 and older in the NIH All of Us Research Program.
Of those participants, 3,026 had ADHD. During follow-up, 6.7% of participants with ADHD developed mild cognitive impairment or dementia compared with 3.4% of participants without ADHD.
After statistical adjustment, an ADHD diagnosis was associated with a 4.6-fold higher hazard of cognitive impairment.
Importantly, the researchers also looked at genetic liability for ADHD using polygenic risk scores. People in the highest ADHD polygenic-risk group had a 35% higher hazard of cognitive impairment than people in the lowest group. That genetic finding makes the association harder to explain entirely through diagnostic bias or increased contact with the health care system.
Still, those numbers need context.
An association is not the same thing as causation.
Does ADHD cause dementia?
We do not know.
This was an observational study. It cannot establish that ADHD directly causes Alzheimer's disease, dementia, or mild cognitive impairment.
The researchers themselves emphasized several possible explanations. Reverse causation is one concern because the earliest stages of neurodegenerative disease can begin many years before dementia is diagnosed and can look surprisingly similar to ADHD. Problems with memory, organization, attention, planning, and executive functioning can occur in both conditions.
When researchers required increasingly long gaps between ADHD diagnosis and cognitive impairment, the association became smaller. It remained statistically significant through an eight-year lag but was no longer significant with a nine-year lag, although the number of available cases had also fallen substantially.
So this study should not make someone with ADHD assume that dementia is in their future.
Instead, I think it should change the question from:
“How do I control my ADHD symptoms today?”
to:
“How do I protect my functioning and brain health over the next several decades?”
That is a much more useful question.
Why might ADHD be associated with cognitive decline later in life?
There are probably multiple pathways, and this is where the study becomes particularly relevant to integrative psychiatry.
The authors proposed two major possibilities.
The first involves cognitive reserve. People with ADHD can have lifelong differences in attention, working memory, inhibition, and executive functioning. One possibility is that having a somewhat lower baseline level of cognitive reserve makes the brain more vulnerable when normal aging or neurodegenerative changes begin accumulating later in life.
The second possibility may be even more clinically actionable.
Over a lifetime, ADHD can increase exposure to other factors associated with cognitive decline, including sleep disturbance, chronic stress, physical inactivity, poor diet quality, cardiometabolic disease, substance use, injuries, and social difficulties. The JAMA Psychiatry authors specifically highlighted many of these pathways.
That matters because many of these variables are potentially modifiable.
This is why treating ADHD exclusively by adjusting a stimulant every few months misses a major part of the picture.
Does ADHD medication prevent dementia?
We do not know yet, but probably not.
The new JAMA Psychiatry study could not adequately determine whether pharmacologic or nonpharmacologic ADHD treatment changed the risk of cognitive impairment. The authors specifically identified this as an important unanswered question.
There is, however, an interesting clue from earlier research.
A 2023 JAMA Network Open study followed more than 109,000 older adults for up to 17.2 years. Adult ADHD was associated with a 2.77-fold higher risk of dementia overall, but researchers did not find a clear increase in dementia risk among the subgroup with ADHD who had been treated with psychostimulants.
That finding does not prove stimulants protect against dementia. Only 22.3% of the ADHD group had stimulant exposure, and observational research like this is highly vulnerable to confounding.
The authors explicitly cautioned against using stimulants as a dementia-prevention treatment based on these results.
For now, medication should be prescribed because it improves ADHD when the benefits outweigh the risks, not because we believe it prevents dementia.
Are stimulant medications unsafe to use long term?
Maybe, but probably not.
The cardiovascular evidence is mixed, and for many adults the benefits of appropriately prescribed stimulant medication can be substantial.
A large Swedish study published in JAMA Psychiatry found that longer cumulative exposure to ADHD medication was associated with higher cardiovascular disease risk, particularly hypertension and arterial disease.
More than five years of medication exposure was associated with an adjusted 23% increase in overall cardiovascular disease and an 80% increase in hypertension compared with nonuse.
On the other hand, a large systematic review and meta-analysis did not find a statistically significant overall association between ADHD medication and cardiovascular disease across age groups, although the authors noted that modest risks could not be excluded and that more long-term data were needed.
Among adults age 66 and older, stimulant initiation has also been associated with a short-term increase in cardiovascular events, although that association was not seen with longer-term use.
The takeaway is not that everyone should stop stimulants.
The takeaway is that medication should not be placed on autopilot for 30 years.
A 30-year-old with excellent blood pressure, sleep, metabolic health, and few other medications is not physiologically identical to that same person at 55, 65, or 75.
Treatment should evolve with the patient.
Why isn't medication alone enough for long-term ADHD treatment?
Medication can make ADHD easier to manage, but it cannot build an entire healthy life for you.
A stimulant may make it easier to exercise, prepare food, organize your day, go to therapy, finish your work, or get to bed on time. That can be incredibly valuable.
But the medication cannot actually perform those behaviors.
This distinction becomes more important as we think about ADHD across decades rather than across a workday.
In my practice, I often think of medication as a set of bumpers.
Good medication management can keep someone from constantly going into the gutter, but the goal should still be to build a life in which the brain is not being asked to compensate for chronic sleep deprivation, overwhelming work demands, poor nutrition, inactivity, untreated anxiety, relationship stress, or an environment fundamentally incompatible with the person.
Sometimes the best ADHD intervention is a medication adjustment.
Sometimes it is changing jobs.
Sometimes it is exercising consistently.
Sometimes it is treating sleep apnea.
Sometimes it is learning how to structure a day around an ADHD brain instead of repeatedly demanding that the brain function like someone else's.
Those interventions are not alternatives to legitimate ADHD treatment.
They are ADHD treatment.
What should integrative ADHD treatment include?
Long-term ADHD care should gradually build several layers of protection around the patient rather than relying on one medication to carry the entire load.
Exercise
Exercise is one of the most interesting nonpharmacologic ADHD interventions because it potentially addresses both current symptoms and long-term health.
A 2026 systematic review and meta-analysis found that acute exercise produced a moderate improvement in inhibitory control and a smaller improvement in core ADHD symptoms in adults.
Evidence regarding chronic exercise and ADHD symptoms remains less certain, but regular physical activity also has broader cardiovascular and cognitive benefits.
Separate prospective research has associated higher physical activity with lower Alzheimer's disease risk, although observational data cannot prove causation.
Sleep and circadian rhythm
Sleep problems are extraordinarily common in ADHD and can make attention, working memory, emotional regulation, motivation, and impulse control considerably worse.
Research suggests that roughly 60% of adults presenting for ADHD treatment may screen positive for a sleep disorder.
Delayed sleep phase, insomnia, and restless legs or periodic limb movement symptoms are particularly common.
Before increasing medication because someone's ADHD seems worse, it is worth asking whether the brain is simply exhausted.
Nutrition and metabolic health
There is no single “ADHD diet,” and nutrition should not be marketed as a replacement for evidence-based ADHD treatment.
But metabolic and vascular health matter enormously over decades.
Higher adherence to Mediterranean-style dietary patterns has repeatedly been associated with lower rates of cognitive impairment and dementia in observational research. A 2024 meta-analysis of 21 studies found lower dementia risk among people with greater Mediterranean diet adherence.
For me, the practical goal is less about following a branded diet and more about creating a sustainable pattern built around minimally processed foods, adequate protein and fiber, plants, healthy fats, and good metabolic health.
Psychological and executive-function skills
Medication may improve attention, but people still need systems.
Modern ADHD treatment should include strategies for planning, prioritizing, emotional regulation, procrastination, avoidance, perfectionism, relationships, and the often significant shame people develop after decades of struggling with ADHD.
Recent meta-analytic evidence supports cognitive behavioral therapy for core ADHD symptoms and executive functioning, with different therapy formats appearing useful for different outcomes.
Cardiovascular health
Blood pressure, resting heart rate, exercise capacity, smoking, cholesterol, glucose regulation, and body composition become progressively more relevant as someone with ADHD ages.
This is especially important when stimulant medication is part of the treatment plan.
The objective should not be to eliminate medication at all costs. It should be to use the lowest effective treatment burden while simultaneously improving the health of the system receiving the medication.
Stress, relationships, purpose, and environment
ADHD does not exist in a vacuum.
A person's symptoms can look dramatically different depending on whether they are sleeping well, working in a job that fits them, connected to other people, physically active, using substances regularly, chronically overwhelmed, or living according to values that actually matter to them.
Medication cannot compensate indefinitely for an environment that is fundamentally unsustainable.
Should adults with ADHD be worried about dementia?
They should be informed, not frightened.
The current evidence suggests that ADHD may be associated with increased vulnerability to cognitive impairment later in life. It does not tell us that an individual with ADHD will develop dementia, and it does not yet tell us exactly why the association exists.
What it does offer is another argument for taking ADHD seriously across the lifespan.
If you are 30, 40, or 50 years old, brain health at 70 is not something that suddenly begins at 69.
The habits and health conditions accumulated over decades matter.
That means good ADHD treatment should help you function better today while simultaneously making it easier to build the behaviors that protect tomorrow.
What does this mean for how I treat adult ADHD?
At Proactive Psychiatry, I do not see medication and lifestyle as competing philosophies.
Medication can be one of the most effective tools we have for ADHD. For the right patient, it can meaningfully improve attention, executive functioning, relationships, occupational performance, and quality of life.
But I also do not think the endpoint of psychiatric care should be finding a dose of medication and renewing it indefinitely.
The better question is whether treatment is helping someone construct a healthier, more functional, more sustainable life.
That means periodically reconsidering medication dose and formulation while also looking at sleep, exercise, nutrition, cardiovascular health, stress, psychotherapy, routines, relationships, work, and the environment around the patient.
For those seeking ADHD treatment in Washington, DC and the surrounding DMV region, that broader approach is a major part of how I think about long-term psychiatric care.
Because the goal should not simply be better concentration this afternoon.
It should be helping the brain work as well as possible for decades to come.
References
Bauer-Negrini G, Leffa DT, Ferreira PCL, et al. Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment. JAMA Psychiatry. Published online October 7, 2026. doi:10.1001/jamapsychiatry.2026.3165.
Levine SZ, Rotstein A, Kodesh A, et al. Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia. JAMA Network Open. 2023;6. doi:10.1001/jamanetworkopen.2023.38088.
Zhang L, Li L, Andell P, et al. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases. JAMA Psychiatry. 2024;81(2):178-187. doi:10.1001/jamapsychiatry.2023.4294.
Li Y, Zhang L. Efficacy of Cognitive Behavioral Therapy Combined with Pharmacotherapy Versus Pharmacotherapy Alone in Adult ADHD: A Systematic Review and Meta-Analysis. Journal of Attention Disorders. 2024;28(3):279-292.
The effects of acute and chronic exercise on executive functions and core symptoms in adults with ADHD: A systematic review and meta-analysis. 2026.
Nucci D, et al. Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysis. Aging Clinical and Experimental Research. 2024;36:77.
Comments